Published March 2018 | Version v1
Journal article Metadata-only

Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study

Creators

  • 1. Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston (United States)
  • 2. Department of Medical Physics, University of Texas MD Anderson Cancer Center, Houston (United States)

Description

To establish, in the phase 1 portion of a prospective phase 1/2 study, the maximum tolerated dose of image guided intensity modulated radiation therapy (IMRT) or proton therapy (IMPT), both with a simultaneous integrated boost (SIB), for patients with stage II to IIIB non-small cell lung cancer receiving concurrent chemoradiation therapy.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2017.10.042

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2017.10.042;
PII
S0360301617340555;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
100
Journal Issue
3
Journal Page Range
p. 730-737
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54107050
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CHEMOTHERAPY; LUNGS; NEOPLASMS; PATIENTS; PHOTONS; PROTON BEAMS; RADIATION DOSES; RADIOTHERAPY
Descriptors DEC
BEAMS; BODY; BOSONS; DISEASES; DOSES; ELEMENTARY PARTICLES; MASSLESS PARTICLES; MEDICINE; NUCLEAR MEDICINE; NUCLEON BEAMS; ORGANS; PARTICLE BEAMS; RADIOLOGY; RESPIRATORY SYSTEM; THERAPY

Optional Information

Notes
Published by Elsevier Inc.